Arcturus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.041; its P/E ratio is -26.54; Arcturus Therapeutics is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-1.11. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 45.14M	$ 10.52M	$ 80.28M	$ 160.29M	$ 13.37M
Gross Profit	$ 45.14M	$ 10.52M	$ 80.28M	$ 160.29M	-
EBIT	$ -15.33M	$ -51.97M	$ 50.86M	$ 119.14M	$ -34.50M
EBITDA	$ -14.50M	$ -51.24M	$ 51.44M	$ 118.24M	$ -34.08M
Net Income Common Stockholders	$ -16.22M	$ -52.55M	$ 50.75M	$ 117.35M	$ -35.27M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 311.92M	$ 323.47M	$ 327.94M	$ 391.88M	$ 237.68M
Total Assets	$ 457.65M	$ 430.65M	$ 470.86M	$ 450.39M	$ 293.63M
Total Debt	$ 47.02M	$ 28.11M	$ 29.19M	$ 90.87M	$ 94.74M
Net Debt	$ -264.90M	$ -295.36M	$ -298.75M	$ -301.01M	$ -142.94M
Total Liabilities	$ 177.59M	$ 145.47M	$ 141.62M	$ 180.07M	$ 147.96M
Stockholders Equity	$ 280.06M	$ 285.21M	$ 329.25M	$ 270.31M	$ 145.67M
Cash Flow	-
Free Cash Flow	$ -33.39M	$ 50.45M	$ -36.56M	$ 156.45M	$ -44.59M
Operating Cash Flow	$ -32.41M	$ 50.81M	$ -35.87M	$ 160.26M	$ -42.41M
Investing Cash Flow	$ -981.00K	$ -354.00K	$ -691.00K	$ -3.81M	$ -2.19M
Financing Cash Flow	$ 21.84M	$ 94.00K	$ -27.36M	$ -2.23M	$ -1.22M

Currency in USD

Arcturus Therapeutics Earnings and Revenue History

Income Statement >

Arcturus Therapeutics Debt to Assets

Balance Sheet >

Arcturus Therapeutics Cash Flow

Cash Flow >

Arcturus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing